Today: 16 April 2026

Leokadia Głogulska

Smart Home Showdown 2025: Google Nest vs Alexa, HomeKit & the Rest – Which Ecosystem Rules?

The Post-Assistant Era: Google’s Gemini Comes Home – What It Means for Your Smart Home

Google will replace Google Assistant with Gemini on Nest smart speakers and displays, starting early access in October 2025. New Nest hardware, including 2K HDR cameras and a Gemini-powered smart speaker, is expected this fall. Google plans to launch a “Google Home Premium” subscription with advanced AI features. Support for 1st- and 2nd-gen Nest Learning Thermostats ends October 2025, limiting them to manual use.

Stock Market Today

  • Snap Shares Rise 7.9% on Volume Surge Amid Mixed Earnings Forecasts
    April 16, 2026, 6:27 AM EDT. Snap Inc. (SNAP) shares jumped 7.9% to $6.04 on heavy trading volume, marking a 20.4% gain over four weeks. Growth drivers include user base expansion, faster subscription uptake, and ad efficiency gains via AI tools. The company is set to report quarterly earnings of $0.08 per share, doubling year-over-year, with revenue expected up 11.8% at $1.52 billion. However, earnings estimates have fallen 9.3% in the past month, signaling possible headwinds. Snap holds a Zacks Rank #3 (Hold). By contrast, peer nCino (NCNO) gained 3.5% with a strong 42.9% upward revision of EPS forecasts and a Zacks Rank #1 (Strong Buy). Investors are advised to monitor Snap for signs of continued momentum amid mixed signals on earnings trends.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 16.04.2026

16 April 2026
LIVEMarkets rolling coverageStarted: April 16, 2026, 12:00 AM EDTUpdated: April 16, 2026, 6:38 AM EDT Snap Shares Rise 7.9% on Volume Surge Amid Mixed Earnings Forecasts April 16, 2026, 6:27 AM EDT. Snap Inc. (SNAP) shares jumped 7.9% to $6.04 on heavy trading volume, marking a 20.4% gain over four weeks. Growth drivers include user base expansion, faster subscription uptake, and ad efficiency gains via AI tools. The company is set to report quarterly earnings of $0.08 per share, doubling year-over-year, with revenue expected up 11.8% at $1.52 billion. However, earnings estimates have fallen 9.3% in the past month, signaling
Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Go toTop